Global Microfluidic in Vitro Diagnostics Market Growth (Status and Outlook) 2026-2032
The global Microfluidic in Vitro Diagnostics market size is predicted to grow from US$ 9040 million in 2025 to US$ 21870 million in 2032; it is expected to grow at a CAGR of 13.7% from 2026 to 2032.
Microfluidic in vitro diagnostics (microfluidic IVD) integrates microscale fluid manipulation with molecular and biochemical detection methods to create lab-on-a-chip or single-use cartridge solutions for rapid processing and testing of biological samples such as blood, saliva, and swabs. By combining microchannels, micropumps, microvalves and integrated sensing units, microfluidic IVD achieves high integration and automation, significantly shortening workflows while improving sensitivity and reproducibility. These systems can deliver end-to-end sample preparation and result readout across clinical laboratories, primary care and point-of-care settings, offering portability with scalable throughput. With advances in automated manufacturing, reagent lyophilization and digital data platforms, microfluidic IVD is positioned as a core technology to enable diagnostic decentralization, strengthen public-health responsiveness, and support personalized testing strategies.
Microfluidic IVD is poised at an industrial inflection point. Major diagnostics companies emphasize “faster, smaller, smarter” strategies in their annual reports, pushing technologies from centralized labs toward point-of-care scenarios and creating a commercialization window for microfluidic solutions. At the same time, regulators’ increasing focus on POCT and novel IVDs, along with modernized approval pathways, provides policy space for clinical adoption and market rollout. Capital markets and M&A are also targeting companies that can deliver “chip-based + digital” integrated solutions, which unlocks R&D resources and accelerates ecosystem aggregation. For firms seeking differentiated, high-value offerings, microfluidics represents both a technical moat and an accelerator for commercialization.
Despite clear opportunities, commercialization is challenging. Key issues stem from manufacturing and quality control: from microstructure fabrication to batch consistency and stable reagent integration, every step demands stringent engineering and scale-up capability. Regulatory and clinical validation uncertainties can prolong time-to-market and increase upfront capital needs. Geopolitical and procurement policy shifts also make supply-chain resilience a critical competitive factor; companies overly dependent on imported materials or equipment may face forced adjustments. Firms must find a pragmatic balance between innovation speed and regulatory cadence to avoid leading technically but lagging commercially.
Downstream demand is evolving from “result-centric” to “scenario- and connectivity-centric.” Hospitals and clinical labs maintain rigid requirements for accuracy and reproducibility, while community care, corporate testing and at-home health management increasingly prioritize portability, cost and immediate feedback. Pharma and biotech companies’ willingness to collaborate on companion diagnostics and rapid screening creates pathways for microfluidic platforms to move into higher-value healthcare services. For marketing and BD teams, positioning microfluidic products as “clinically trusted point-of-care solutions” with seamless digital integration will be a persuasive narrative for both procurement decision-makers and investors.
The microfluidic upstream ecosystem centers on materials, precision manufacturing, and surface chemistry. High-performance polymers and functional coatings determine chip processability and biocompatibility; glass and silicon remain indispensable for high-end optical and thermal applications; and specialized reagents for surface modification and biomolecule immobilization directly affect assay sensitivity and specificity. Annual reports and regulatory documents indicate that as countries promote localized medical device supply chains, regionalization of materials and manufacturing becomes increasingly important. Firms that control key upstream materials and processes will be better positioned on price, delivery and compliance, creating durable competitive barriers.
This Insight Report provides a comprehensive analysis of the global Microfluidic in Vitro Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Microfluidic in Vitro Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microfluidic in Vitro Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microfluidic in Vitro Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microfluidic in Vitro Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Microfluidic in Vitro Diagnostics market by product type, application, key players and key regions and countries.
Microfluidic in vitro diagnostics (microfluidic IVD) integrates microscale fluid manipulation with molecular and biochemical detection methods to create lab-on-a-chip or single-use cartridge solutions for rapid processing and testing of biological samples such as blood, saliva, and swabs. By combining microchannels, micropumps, microvalves and integrated sensing units, microfluidic IVD achieves high integration and automation, significantly shortening workflows while improving sensitivity and reproducibility. These systems can deliver end-to-end sample preparation and result readout across clinical laboratories, primary care and point-of-care settings, offering portability with scalable throughput. With advances in automated manufacturing, reagent lyophilization and digital data platforms, microfluidic IVD is positioned as a core technology to enable diagnostic decentralization, strengthen public-health responsiveness, and support personalized testing strategies.
Microfluidic IVD is poised at an industrial inflection point. Major diagnostics companies emphasize “faster, smaller, smarter” strategies in their annual reports, pushing technologies from centralized labs toward point-of-care scenarios and creating a commercialization window for microfluidic solutions. At the same time, regulators’ increasing focus on POCT and novel IVDs, along with modernized approval pathways, provides policy space for clinical adoption and market rollout. Capital markets and M&A are also targeting companies that can deliver “chip-based + digital” integrated solutions, which unlocks R&D resources and accelerates ecosystem aggregation. For firms seeking differentiated, high-value offerings, microfluidics represents both a technical moat and an accelerator for commercialization.
Despite clear opportunities, commercialization is challenging. Key issues stem from manufacturing and quality control: from microstructure fabrication to batch consistency and stable reagent integration, every step demands stringent engineering and scale-up capability. Regulatory and clinical validation uncertainties can prolong time-to-market and increase upfront capital needs. Geopolitical and procurement policy shifts also make supply-chain resilience a critical competitive factor; companies overly dependent on imported materials or equipment may face forced adjustments. Firms must find a pragmatic balance between innovation speed and regulatory cadence to avoid leading technically but lagging commercially.
Downstream demand is evolving from “result-centric” to “scenario- and connectivity-centric.” Hospitals and clinical labs maintain rigid requirements for accuracy and reproducibility, while community care, corporate testing and at-home health management increasingly prioritize portability, cost and immediate feedback. Pharma and biotech companies’ willingness to collaborate on companion diagnostics and rapid screening creates pathways for microfluidic platforms to move into higher-value healthcare services. For marketing and BD teams, positioning microfluidic products as “clinically trusted point-of-care solutions” with seamless digital integration will be a persuasive narrative for both procurement decision-makers and investors.
The microfluidic upstream ecosystem centers on materials, precision manufacturing, and surface chemistry. High-performance polymers and functional coatings determine chip processability and biocompatibility; glass and silicon remain indispensable for high-end optical and thermal applications; and specialized reagents for surface modification and biomolecule immobilization directly affect assay sensitivity and specificity. Annual reports and regulatory documents indicate that as countries promote localized medical device supply chains, regionalization of materials and manufacturing becomes increasingly important. Firms that control key upstream materials and processes will be better positioned on price, delivery and compliance, creating durable competitive barriers.
Report Scope
LPI (LP Information)' newest research report, the “Microfluidic in Vitro Diagnostics Industry Forecast” looks at past sales and reviews total world Microfluidic in Vitro Diagnostics sales in 2025, providing a comprehensive analysis by region and market sector of projected Microfluidic in Vitro Diagnostics sales for 2026 through 2032. With Microfluidic in Vitro Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microfluidic in Vitro Diagnostics industry.This Insight Report provides a comprehensive analysis of the global Microfluidic in Vitro Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Microfluidic in Vitro Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microfluidic in Vitro Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microfluidic in Vitro Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microfluidic in Vitro Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Microfluidic in Vitro Diagnostics market by product type, application, key players and key regions and countries.
Market Segmentation
Segmentation by Type:
- Biochemical Diagnosis
- Molecular Diagnosis
- POCT
- Other
Segmentation by Application:
- Hospital
- Third-party Laboratory
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Danaher (Cephi)
- Roche
- Abbott
- bioM?rieux
- Hologic
- Thermo Fisher Scientific
- Revitty
- Agilent Technologies
- Bio-Rad Laboratories
- Illumina
- Bohui-TECH
- Bio-Biotech
- Sinxiang Biotech
- Kayoudi
- Hangzhou Ustar
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Microfluidic in Vitro Diagnostics Market Size (2021-2032)
2.1.2 Microfluidic in Vitro Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Microfluidic in Vitro Diagnostics by Country/Region (2021, 2025 & 2032)
2.2 Microfluidic in Vitro Diagnostics Segment by Type
2.2.1 Biochemical Diagnosis
2.2.2 Molecular Diagnosis
2.2.3 POCT
2.2.4 Other
2.2.5 Microfluidic in Vitro Diagnostics Market Size by Type
2.2.5.1 Microfluidic in Vitro Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Microfluidic in Vitro Diagnostics Market Size Market Share by Type (2021-2026)
2.3 Microfluidic in Vitro Diagnostics Segment by Application
2.3.1 Hospital
2.3.2 Third-party Laboratory
2.3.3 Other
2.3.4 Microfluidic in Vitro Diagnostics Market Size by Application
2.3.4.1 Microfluidic in Vitro Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Microfluidic in Vitro Diagnostics Market Size Market Share by Application (2021-2026)
3 MICROFLUIDIC IN VITRO DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Microfluidic in Vitro Diagnostics Market Size Market Share by Player
3.1.1 Global Microfluidic in Vitro Diagnostics Revenue by Player (2021-2026)
3.1.2 Global Microfluidic in Vitro Diagnostics Revenue Market Share by Player (2021-2026)
3.2 Global Microfluidic in Vitro Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MICROFLUIDIC IN VITRO DIAGNOSTICS BY REGION
4.1 Microfluidic in Vitro Diagnostics Market Size by Region (2021-2026)
4.2 Global Microfluidic in Vitro Diagnostics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Microfluidic in Vitro Diagnostics Market Size Growth (2021-2026)
4.4 APAC Microfluidic in Vitro Diagnostics Market Size Growth (2021-2026)
4.5 Europe Microfluidic in Vitro Diagnostics Market Size Growth (2021-2026)
4.6 Middle East & Africa Microfluidic in Vitro Diagnostics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Microfluidic in Vitro Diagnostics Market Size by Country (2021-2026)
5.2 Americas Microfluidic in Vitro Diagnostics Market Size by Type (2021-2026)
5.3 Americas Microfluidic in Vitro Diagnostics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Microfluidic in Vitro Diagnostics Market Size by Region (2021-2026)
6.2 APAC Microfluidic in Vitro Diagnostics Market Size by Type (2021-2026)
6.3 APAC Microfluidic in Vitro Diagnostics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Microfluidic in Vitro Diagnostics Market Size by Country (2021-2026)
7.2 Europe Microfluidic in Vitro Diagnostics Market Size by Type (2021-2026)
7.3 Europe Microfluidic in Vitro Diagnostics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Microfluidic in Vitro Diagnostics by Region (2021-2026)
8.2 Middle East & Africa Microfluidic in Vitro Diagnostics Market Size by Type (2021-2026)
8.3 Middle East & Africa Microfluidic in Vitro Diagnostics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MICROFLUIDIC IN VITRO DIAGNOSTICS MARKET FORECAST
10.1 Global Microfluidic in Vitro Diagnostics Forecast by Region (2027-2032)
10.1.1 Global Microfluidic in Vitro Diagnostics Forecast by Region (2027-2032)
10.1.2 Americas Microfluidic in Vitro Diagnostics Forecast
10.1.3 APAC Microfluidic in Vitro Diagnostics Forecast
10.1.4 Europe Microfluidic in Vitro Diagnostics Forecast
10.1.5 Middle East & Africa Microfluidic in Vitro Diagnostics Forecast
10.2 Americas Microfluidic in Vitro Diagnostics Forecast by Country (2027-2032)
10.2.1 United States Market Microfluidic in Vitro Diagnostics Forecast
10.2.2 Canada Market Microfluidic in Vitro Diagnostics Forecast
10.2.3 Mexico Market Microfluidic in Vitro Diagnostics Forecast
10.2.4 Brazil Market Microfluidic in Vitro Diagnostics Forecast
10.3 APAC Microfluidic in Vitro Diagnostics Forecast by Region (2027-2032)
10.3.1 China Microfluidic in Vitro Diagnostics Market Forecast
10.3.2 Japan Market Microfluidic in Vitro Diagnostics Forecast
10.3.3 Korea Market Microfluidic in Vitro Diagnostics Forecast
10.3.4 Southeast Asia Market Microfluidic in Vitro Diagnostics Forecast
10.3.5 India Market Microfluidic in Vitro Diagnostics Forecast
10.3.6 Australia Market Microfluidic in Vitro Diagnostics Forecast
10.4 Europe Microfluidic in Vitro Diagnostics Forecast by Country (2027-2032)
10.4.1 Germany Market Microfluidic in Vitro Diagnostics Forecast
10.4.2 France Market Microfluidic in Vitro Diagnostics Forecast
10.4.3 UK Market Microfluidic in Vitro Diagnostics Forecast
10.4.4 Italy Market Microfluidic in Vitro Diagnostics Forecast
10.4.5 Russia Market Microfluidic in Vitro Diagnostics Forecast
10.5 Middle East & Africa Microfluidic in Vitro Diagnostics Forecast by Region (2027-2032)
10.5.1 Egypt Market Microfluidic in Vitro Diagnostics Forecast
10.5.2 South Africa Market Microfluidic in Vitro Diagnostics Forecast
10.5.3 Israel Market Microfluidic in Vitro Diagnostics Forecast
10.5.4 Turkey Market Microfluidic in Vitro Diagnostics Forecast
10.6 Global Microfluidic in Vitro Diagnostics Forecast by Type (2027-2032)
10.7 Global Microfluidic in Vitro Diagnostics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Microfluidic in Vitro Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Danaher (Cephi)
11.1.1 Danaher (Cephi) Company Information
11.1.2 Danaher (Cephi) Microfluidic in Vitro Diagnostics Product Offered
11.1.3 Danaher (Cephi) Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Danaher (Cephi) Main Business Overview
11.1.5 Danaher (Cephi) Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Microfluidic in Vitro Diagnostics Product Offered
11.2.3 Roche Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Microfluidic in Vitro Diagnostics Product Offered
11.3.3 Abbott Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 bioM?rieux
11.4.1 bioM?rieux Company Information
11.4.2 bioM?rieux Microfluidic in Vitro Diagnostics Product Offered
11.4.3 bioM?rieux Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 bioM?rieux Main Business Overview
11.4.5 bioM?rieux Latest Developments
11.5 Hologic
11.5.1 Hologic Company Information
11.5.2 Hologic Microfluidic in Vitro Diagnostics Product Offered
11.5.3 Hologic Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Hologic Main Business Overview
11.5.5 Hologic Latest Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Information
11.6.2 Thermo Fisher Scientific Microfluidic in Vitro Diagnostics Product Offered
11.6.3 Thermo Fisher Scientific Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Thermo Fisher Scientific Main Business Overview
11.6.5 Thermo Fisher Scientific Latest Developments
11.7 Revitty
11.7.1 Revitty Company Information
11.7.2 Revitty Microfluidic in Vitro Diagnostics Product Offered
11.7.3 Revitty Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Revitty Main Business Overview
11.7.5 Revitty Latest Developments
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Information
11.8.2 Agilent Technologies Microfluidic in Vitro Diagnostics Product Offered
11.8.3 Agilent Technologies Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Agilent Technologies Main Business Overview
11.8.5 Agilent Technologies Latest Developments
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Information
11.9.2 Bio-Rad Laboratories Microfluidic in Vitro Diagnostics Product Offered
11.9.3 Bio-Rad Laboratories Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Bio-Rad Laboratories Main Business Overview
11.9.5 Bio-Rad Laboratories Latest Developments
11.10 Illumina
11.10.1 Illumina Company Information
11.10.2 Illumina Microfluidic in Vitro Diagnostics Product Offered
11.10.3 Illumina Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Illumina Main Business Overview
11.10.5 Illumina Latest Developments
11.11 Bohui-TECH
11.11.1 Bohui-TECH Company Information
11.11.2 Bohui-TECH Microfluidic in Vitro Diagnostics Product Offered
11.11.3 Bohui-TECH Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Bohui-TECH Main Business Overview
11.11.5 Bohui-TECH Latest Developments
11.12 Bio-Biotech
11.12.1 Bio-Biotech Company Information
11.12.2 Bio-Biotech Microfluidic in Vitro Diagnostics Product Offered
11.12.3 Bio-Biotech Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Bio-Biotech Main Business Overview
11.12.5 Bio-Biotech Latest Developments
11.13 Sinxiang Biotech
11.13.1 Sinxiang Biotech Company Information
11.13.2 Sinxiang Biotech Microfluidic in Vitro Diagnostics Product Offered
11.13.3 Sinxiang Biotech Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Sinxiang Biotech Main Business Overview
11.13.5 Sinxiang Biotech Latest Developments
11.14 Kayoudi
11.14.1 Kayoudi Company Information
11.14.2 Kayoudi Microfluidic in Vitro Diagnostics Product Offered
11.14.3 Kayoudi Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Kayoudi Main Business Overview
11.14.5 Kayoudi Latest Developments
11.15 Hangzhou Ustar
11.15.1 Hangzhou Ustar Company Information
11.15.2 Hangzhou Ustar Microfluidic in Vitro Diagnostics Product Offered
11.15.3 Hangzhou Ustar Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Hangzhou Ustar Main Business Overview
11.15.5 Hangzhou Ustar Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Microfluidic in Vitro Diagnostics Market Size (2021-2032)
2.1.2 Microfluidic in Vitro Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Microfluidic in Vitro Diagnostics by Country/Region (2021, 2025 & 2032)
2.2 Microfluidic in Vitro Diagnostics Segment by Type
2.2.1 Biochemical Diagnosis
2.2.2 Molecular Diagnosis
2.2.3 POCT
2.2.4 Other
2.2.5 Microfluidic in Vitro Diagnostics Market Size by Type
2.2.5.1 Microfluidic in Vitro Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Microfluidic in Vitro Diagnostics Market Size Market Share by Type (2021-2026)
2.3 Microfluidic in Vitro Diagnostics Segment by Application
2.3.1 Hospital
2.3.2 Third-party Laboratory
2.3.3 Other
2.3.4 Microfluidic in Vitro Diagnostics Market Size by Application
2.3.4.1 Microfluidic in Vitro Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Microfluidic in Vitro Diagnostics Market Size Market Share by Application (2021-2026)
3 MICROFLUIDIC IN VITRO DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Microfluidic in Vitro Diagnostics Market Size Market Share by Player
3.1.1 Global Microfluidic in Vitro Diagnostics Revenue by Player (2021-2026)
3.1.2 Global Microfluidic in Vitro Diagnostics Revenue Market Share by Player (2021-2026)
3.2 Global Microfluidic in Vitro Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MICROFLUIDIC IN VITRO DIAGNOSTICS BY REGION
4.1 Microfluidic in Vitro Diagnostics Market Size by Region (2021-2026)
4.2 Global Microfluidic in Vitro Diagnostics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Microfluidic in Vitro Diagnostics Market Size Growth (2021-2026)
4.4 APAC Microfluidic in Vitro Diagnostics Market Size Growth (2021-2026)
4.5 Europe Microfluidic in Vitro Diagnostics Market Size Growth (2021-2026)
4.6 Middle East & Africa Microfluidic in Vitro Diagnostics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Microfluidic in Vitro Diagnostics Market Size by Country (2021-2026)
5.2 Americas Microfluidic in Vitro Diagnostics Market Size by Type (2021-2026)
5.3 Americas Microfluidic in Vitro Diagnostics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Microfluidic in Vitro Diagnostics Market Size by Region (2021-2026)
6.2 APAC Microfluidic in Vitro Diagnostics Market Size by Type (2021-2026)
6.3 APAC Microfluidic in Vitro Diagnostics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Microfluidic in Vitro Diagnostics Market Size by Country (2021-2026)
7.2 Europe Microfluidic in Vitro Diagnostics Market Size by Type (2021-2026)
7.3 Europe Microfluidic in Vitro Diagnostics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Microfluidic in Vitro Diagnostics by Region (2021-2026)
8.2 Middle East & Africa Microfluidic in Vitro Diagnostics Market Size by Type (2021-2026)
8.3 Middle East & Africa Microfluidic in Vitro Diagnostics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MICROFLUIDIC IN VITRO DIAGNOSTICS MARKET FORECAST
10.1 Global Microfluidic in Vitro Diagnostics Forecast by Region (2027-2032)
10.1.1 Global Microfluidic in Vitro Diagnostics Forecast by Region (2027-2032)
10.1.2 Americas Microfluidic in Vitro Diagnostics Forecast
10.1.3 APAC Microfluidic in Vitro Diagnostics Forecast
10.1.4 Europe Microfluidic in Vitro Diagnostics Forecast
10.1.5 Middle East & Africa Microfluidic in Vitro Diagnostics Forecast
10.2 Americas Microfluidic in Vitro Diagnostics Forecast by Country (2027-2032)
10.2.1 United States Market Microfluidic in Vitro Diagnostics Forecast
10.2.2 Canada Market Microfluidic in Vitro Diagnostics Forecast
10.2.3 Mexico Market Microfluidic in Vitro Diagnostics Forecast
10.2.4 Brazil Market Microfluidic in Vitro Diagnostics Forecast
10.3 APAC Microfluidic in Vitro Diagnostics Forecast by Region (2027-2032)
10.3.1 China Microfluidic in Vitro Diagnostics Market Forecast
10.3.2 Japan Market Microfluidic in Vitro Diagnostics Forecast
10.3.3 Korea Market Microfluidic in Vitro Diagnostics Forecast
10.3.4 Southeast Asia Market Microfluidic in Vitro Diagnostics Forecast
10.3.5 India Market Microfluidic in Vitro Diagnostics Forecast
10.3.6 Australia Market Microfluidic in Vitro Diagnostics Forecast
10.4 Europe Microfluidic in Vitro Diagnostics Forecast by Country (2027-2032)
10.4.1 Germany Market Microfluidic in Vitro Diagnostics Forecast
10.4.2 France Market Microfluidic in Vitro Diagnostics Forecast
10.4.3 UK Market Microfluidic in Vitro Diagnostics Forecast
10.4.4 Italy Market Microfluidic in Vitro Diagnostics Forecast
10.4.5 Russia Market Microfluidic in Vitro Diagnostics Forecast
10.5 Middle East & Africa Microfluidic in Vitro Diagnostics Forecast by Region (2027-2032)
10.5.1 Egypt Market Microfluidic in Vitro Diagnostics Forecast
10.5.2 South Africa Market Microfluidic in Vitro Diagnostics Forecast
10.5.3 Israel Market Microfluidic in Vitro Diagnostics Forecast
10.5.4 Turkey Market Microfluidic in Vitro Diagnostics Forecast
10.6 Global Microfluidic in Vitro Diagnostics Forecast by Type (2027-2032)
10.7 Global Microfluidic in Vitro Diagnostics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Microfluidic in Vitro Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Danaher (Cephi)
11.1.1 Danaher (Cephi) Company Information
11.1.2 Danaher (Cephi) Microfluidic in Vitro Diagnostics Product Offered
11.1.3 Danaher (Cephi) Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Danaher (Cephi) Main Business Overview
11.1.5 Danaher (Cephi) Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Microfluidic in Vitro Diagnostics Product Offered
11.2.3 Roche Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Microfluidic in Vitro Diagnostics Product Offered
11.3.3 Abbott Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 bioM?rieux
11.4.1 bioM?rieux Company Information
11.4.2 bioM?rieux Microfluidic in Vitro Diagnostics Product Offered
11.4.3 bioM?rieux Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 bioM?rieux Main Business Overview
11.4.5 bioM?rieux Latest Developments
11.5 Hologic
11.5.1 Hologic Company Information
11.5.2 Hologic Microfluidic in Vitro Diagnostics Product Offered
11.5.3 Hologic Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Hologic Main Business Overview
11.5.5 Hologic Latest Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Information
11.6.2 Thermo Fisher Scientific Microfluidic in Vitro Diagnostics Product Offered
11.6.3 Thermo Fisher Scientific Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Thermo Fisher Scientific Main Business Overview
11.6.5 Thermo Fisher Scientific Latest Developments
11.7 Revitty
11.7.1 Revitty Company Information
11.7.2 Revitty Microfluidic in Vitro Diagnostics Product Offered
11.7.3 Revitty Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Revitty Main Business Overview
11.7.5 Revitty Latest Developments
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Information
11.8.2 Agilent Technologies Microfluidic in Vitro Diagnostics Product Offered
11.8.3 Agilent Technologies Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Agilent Technologies Main Business Overview
11.8.5 Agilent Technologies Latest Developments
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Information
11.9.2 Bio-Rad Laboratories Microfluidic in Vitro Diagnostics Product Offered
11.9.3 Bio-Rad Laboratories Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Bio-Rad Laboratories Main Business Overview
11.9.5 Bio-Rad Laboratories Latest Developments
11.10 Illumina
11.10.1 Illumina Company Information
11.10.2 Illumina Microfluidic in Vitro Diagnostics Product Offered
11.10.3 Illumina Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Illumina Main Business Overview
11.10.5 Illumina Latest Developments
11.11 Bohui-TECH
11.11.1 Bohui-TECH Company Information
11.11.2 Bohui-TECH Microfluidic in Vitro Diagnostics Product Offered
11.11.3 Bohui-TECH Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Bohui-TECH Main Business Overview
11.11.5 Bohui-TECH Latest Developments
11.12 Bio-Biotech
11.12.1 Bio-Biotech Company Information
11.12.2 Bio-Biotech Microfluidic in Vitro Diagnostics Product Offered
11.12.3 Bio-Biotech Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Bio-Biotech Main Business Overview
11.12.5 Bio-Biotech Latest Developments
11.13 Sinxiang Biotech
11.13.1 Sinxiang Biotech Company Information
11.13.2 Sinxiang Biotech Microfluidic in Vitro Diagnostics Product Offered
11.13.3 Sinxiang Biotech Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Sinxiang Biotech Main Business Overview
11.13.5 Sinxiang Biotech Latest Developments
11.14 Kayoudi
11.14.1 Kayoudi Company Information
11.14.2 Kayoudi Microfluidic in Vitro Diagnostics Product Offered
11.14.3 Kayoudi Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Kayoudi Main Business Overview
11.14.5 Kayoudi Latest Developments
11.15 Hangzhou Ustar
11.15.1 Hangzhou Ustar Company Information
11.15.2 Hangzhou Ustar Microfluidic in Vitro Diagnostics Product Offered
11.15.3 Hangzhou Ustar Microfluidic in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Hangzhou Ustar Main Business Overview
11.15.5 Hangzhou Ustar Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Microfluidic in Vitro Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Microfluidic in Vitro Diagnostics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Biochemical Diagnosis
Table 4. Major Players of Molecular Diagnosis
Table 5. Major Players of POCT
Table 6. Major Players of Other
Table 7. Microfluidic in Vitro Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Microfluidic in Vitro Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Microfluidic in Vitro Diagnostics Market Size Market Share by Type (2021-2026)
Table 10. Microfluidic in Vitro Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Microfluidic in Vitro Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Microfluidic in Vitro Diagnostics Market Size Market Share by Application (2021-2026)
Table 13. Global Microfluidic in Vitro Diagnostics Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Microfluidic in Vitro Diagnostics Revenue Market Share by Player (2021-2026)
Table 15. Microfluidic in Vitro Diagnostics Key Players Head office and Products Offered
Table 16. Microfluidic in Vitro Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Microfluidic in Vitro Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Microfluidic in Vitro Diagnostics Market Size Market Share by Region (2021-2026)
Table 21. Global Microfluidic in Vitro Diagnostics Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Microfluidic in Vitro Diagnostics Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Microfluidic in Vitro Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Microfluidic in Vitro Diagnostics Market Size Market Share by Country (2021-2026)
Table 25. Americas Microfluidic in Vitro Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Microfluidic in Vitro Diagnostics Market Size Market Share by Type (2021-2026)
Table 27. Americas Microfluidic in Vitro Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Microfluidic in Vitro Diagnostics Market Size Market Share by Application (2021-2026)
Table 29. APAC Microfluidic in Vitro Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Microfluidic in Vitro Diagnostics Market Size Market Share by Region (2021-2026)
Table 31. APAC Microfluidic in Vitro Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Microfluidic in Vitro Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Microfluidic in Vitro Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Microfluidic in Vitro Diagnostics Market Size Market Share by Country (2021-2026)
Table 35. Europe Microfluidic in Vitro Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Microfluidic in Vitro Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Microfluidic in Vitro Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Microfluidic in Vitro Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Microfluidic in Vitro Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Microfluidic in Vitro Diagnostics
Table 41. Key Market Challenges & Risks of Microfluidic in Vitro Diagnostics
Table 42. Key Industry Trends of Microfluidic in Vitro Diagnostics
Table 43. Global Microfluidic in Vitro Diagnostics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Microfluidic in Vitro Diagnostics Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Microfluidic in Vitro Diagnostics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Microfluidic in Vitro Diagnostics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Danaher (Cephi) Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 48. Danaher (Cephi) Microfluidic in Vitro Diagnostics Product Offered
Table 49. Danaher (Cephi) Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Danaher (Cephi) Main Business
Table 51. Danaher (Cephi) Latest Developments
Table 52. Roche Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 53. Roche Microfluidic in Vitro Diagnostics Product Offered
Table 54. Roche Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Roche Main Business
Table 56. Roche Latest Developments
Table 57. Abbott Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 58. Abbott Microfluidic in Vitro Diagnostics Product Offered
Table 59. Abbott Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Abbott Main Business
Table 61. Abbott Latest Developments
Table 62. bioM?rieux Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 63. bioM?rieux Microfluidic in Vitro Diagnostics Product Offered
Table 64. bioM?rieux Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. bioM?rieux Main Business
Table 66. bioM?rieux Latest Developments
Table 67. Hologic Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 68. Hologic Microfluidic in Vitro Diagnostics Product Offered
Table 69. Hologic Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Hologic Main Business
Table 71. Hologic Latest Developments
Table 72. Thermo Fisher Scientific Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 73. Thermo Fisher Scientific Microfluidic in Vitro Diagnostics Product Offered
Table 74. Thermo Fisher Scientific Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Thermo Fisher Scientific Main Business
Table 76. Thermo Fisher Scientific Latest Developments
Table 77. Revitty Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 78. Revitty Microfluidic in Vitro Diagnostics Product Offered
Table 79. Revitty Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Revitty Main Business
Table 81. Revitty Latest Developments
Table 82. Agilent Technologies Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 83. Agilent Technologies Microfluidic in Vitro Diagnostics Product Offered
Table 84. Agilent Technologies Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Agilent Technologies Main Business
Table 86. Agilent Technologies Latest Developments
Table 87. Bio-Rad Laboratories Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 88. Bio-Rad Laboratories Microfluidic in Vitro Diagnostics Product Offered
Table 89. Bio-Rad Laboratories Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Bio-Rad Laboratories Main Business
Table 91. Bio-Rad Laboratories Latest Developments
Table 92. Illumina Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 93. Illumina Microfluidic in Vitro Diagnostics Product Offered
Table 94. Illumina Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Illumina Main Business
Table 96. Illumina Latest Developments
Table 97. Bohui-TECH Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 98. Bohui-TECH Microfluidic in Vitro Diagnostics Product Offered
Table 99. Bohui-TECH Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Bohui-TECH Main Business
Table 101. Bohui-TECH Latest Developments
Table 102. Bio-Biotech Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 103. Bio-Biotech Microfluidic in Vitro Diagnostics Product Offered
Table 104. Bio-Biotech Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Bio-Biotech Main Business
Table 106. Bio-Biotech Latest Developments
Table 107. Sinxiang Biotech Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 108. Sinxiang Biotech Microfluidic in Vitro Diagnostics Product Offered
Table 109. Sinxiang Biotech Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Sinxiang Biotech Main Business
Table 111. Sinxiang Biotech Latest Developments
Table 112. Kayoudi Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 113. Kayoudi Microfluidic in Vitro Diagnostics Product Offered
Table 114. Kayoudi Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Kayoudi Main Business
Table 116. Kayoudi Latest Developments
Table 117. Hangzhou Ustar Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 118. Hangzhou Ustar Microfluidic in Vitro Diagnostics Product Offered
Table 119. Hangzhou Ustar Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Hangzhou Ustar Main Business
Table 121. Hangzhou Ustar Latest Developments
Table 1. Microfluidic in Vitro Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Microfluidic in Vitro Diagnostics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Biochemical Diagnosis
Table 4. Major Players of Molecular Diagnosis
Table 5. Major Players of POCT
Table 6. Major Players of Other
Table 7. Microfluidic in Vitro Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Microfluidic in Vitro Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Microfluidic in Vitro Diagnostics Market Size Market Share by Type (2021-2026)
Table 10. Microfluidic in Vitro Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Microfluidic in Vitro Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Microfluidic in Vitro Diagnostics Market Size Market Share by Application (2021-2026)
Table 13. Global Microfluidic in Vitro Diagnostics Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Microfluidic in Vitro Diagnostics Revenue Market Share by Player (2021-2026)
Table 15. Microfluidic in Vitro Diagnostics Key Players Head office and Products Offered
Table 16. Microfluidic in Vitro Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Microfluidic in Vitro Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Microfluidic in Vitro Diagnostics Market Size Market Share by Region (2021-2026)
Table 21. Global Microfluidic in Vitro Diagnostics Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Microfluidic in Vitro Diagnostics Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Microfluidic in Vitro Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Microfluidic in Vitro Diagnostics Market Size Market Share by Country (2021-2026)
Table 25. Americas Microfluidic in Vitro Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Microfluidic in Vitro Diagnostics Market Size Market Share by Type (2021-2026)
Table 27. Americas Microfluidic in Vitro Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Microfluidic in Vitro Diagnostics Market Size Market Share by Application (2021-2026)
Table 29. APAC Microfluidic in Vitro Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Microfluidic in Vitro Diagnostics Market Size Market Share by Region (2021-2026)
Table 31. APAC Microfluidic in Vitro Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Microfluidic in Vitro Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Microfluidic in Vitro Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Microfluidic in Vitro Diagnostics Market Size Market Share by Country (2021-2026)
Table 35. Europe Microfluidic in Vitro Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Microfluidic in Vitro Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Microfluidic in Vitro Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Microfluidic in Vitro Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Microfluidic in Vitro Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Microfluidic in Vitro Diagnostics
Table 41. Key Market Challenges & Risks of Microfluidic in Vitro Diagnostics
Table 42. Key Industry Trends of Microfluidic in Vitro Diagnostics
Table 43. Global Microfluidic in Vitro Diagnostics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Microfluidic in Vitro Diagnostics Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Microfluidic in Vitro Diagnostics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Microfluidic in Vitro Diagnostics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Danaher (Cephi) Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 48. Danaher (Cephi) Microfluidic in Vitro Diagnostics Product Offered
Table 49. Danaher (Cephi) Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Danaher (Cephi) Main Business
Table 51. Danaher (Cephi) Latest Developments
Table 52. Roche Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 53. Roche Microfluidic in Vitro Diagnostics Product Offered
Table 54. Roche Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Roche Main Business
Table 56. Roche Latest Developments
Table 57. Abbott Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 58. Abbott Microfluidic in Vitro Diagnostics Product Offered
Table 59. Abbott Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Abbott Main Business
Table 61. Abbott Latest Developments
Table 62. bioM?rieux Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 63. bioM?rieux Microfluidic in Vitro Diagnostics Product Offered
Table 64. bioM?rieux Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. bioM?rieux Main Business
Table 66. bioM?rieux Latest Developments
Table 67. Hologic Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 68. Hologic Microfluidic in Vitro Diagnostics Product Offered
Table 69. Hologic Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Hologic Main Business
Table 71. Hologic Latest Developments
Table 72. Thermo Fisher Scientific Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 73. Thermo Fisher Scientific Microfluidic in Vitro Diagnostics Product Offered
Table 74. Thermo Fisher Scientific Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Thermo Fisher Scientific Main Business
Table 76. Thermo Fisher Scientific Latest Developments
Table 77. Revitty Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 78. Revitty Microfluidic in Vitro Diagnostics Product Offered
Table 79. Revitty Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Revitty Main Business
Table 81. Revitty Latest Developments
Table 82. Agilent Technologies Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 83. Agilent Technologies Microfluidic in Vitro Diagnostics Product Offered
Table 84. Agilent Technologies Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Agilent Technologies Main Business
Table 86. Agilent Technologies Latest Developments
Table 87. Bio-Rad Laboratories Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 88. Bio-Rad Laboratories Microfluidic in Vitro Diagnostics Product Offered
Table 89. Bio-Rad Laboratories Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Bio-Rad Laboratories Main Business
Table 91. Bio-Rad Laboratories Latest Developments
Table 92. Illumina Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 93. Illumina Microfluidic in Vitro Diagnostics Product Offered
Table 94. Illumina Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Illumina Main Business
Table 96. Illumina Latest Developments
Table 97. Bohui-TECH Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 98. Bohui-TECH Microfluidic in Vitro Diagnostics Product Offered
Table 99. Bohui-TECH Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Bohui-TECH Main Business
Table 101. Bohui-TECH Latest Developments
Table 102. Bio-Biotech Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 103. Bio-Biotech Microfluidic in Vitro Diagnostics Product Offered
Table 104. Bio-Biotech Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Bio-Biotech Main Business
Table 106. Bio-Biotech Latest Developments
Table 107. Sinxiang Biotech Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 108. Sinxiang Biotech Microfluidic in Vitro Diagnostics Product Offered
Table 109. Sinxiang Biotech Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Sinxiang Biotech Main Business
Table 111. Sinxiang Biotech Latest Developments
Table 112. Kayoudi Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 113. Kayoudi Microfluidic in Vitro Diagnostics Product Offered
Table 114. Kayoudi Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Kayoudi Main Business
Table 116. Kayoudi Latest Developments
Table 117. Hangzhou Ustar Details, Company Type, Microfluidic in Vitro Diagnostics Area Served and Its Competitors
Table 118. Hangzhou Ustar Microfluidic in Vitro Diagnostics Product Offered
Table 119. Hangzhou Ustar Microfluidic in Vitro Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Hangzhou Ustar Main Business
Table 121. Hangzhou Ustar Latest Developments
LIST OF FIGURES
Figure 1. Microfluidic in Vitro Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Microfluidic in Vitro Diagnostics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Microfluidic in Vitro Diagnostics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Microfluidic in Vitro Diagnostics Sales Market Share by Country/Region (2025)
Figure 8. Microfluidic in Vitro Diagnostics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Microfluidic in Vitro Diagnostics Market Size Market Share by Type in 2025
Figure 10. Microfluidic in Vitro Diagnostics in Hospital
Figure 11. Global Microfluidic in Vitro Diagnostics Market: Hospital (2021-2026) & ($ millions)
Figure 12. Microfluidic in Vitro Diagnostics in Third-party Laboratory
Figure 13. Global Microfluidic in Vitro Diagnostics Market: Third-party Laboratory (2021-2026) & ($ millions)
Figure 14. Microfluidic in Vitro Diagnostics in Other
Figure 15. Global Microfluidic in Vitro Diagnostics Market: Other (2021-2026) & ($ millions)
Figure 16. Global Microfluidic in Vitro Diagnostics Market Size Market Share by Application in 2025
Figure 17. Global Microfluidic in Vitro Diagnostics Revenue Market Share by Player in 2025
Figure 18. Global Microfluidic in Vitro Diagnostics Market Size Market Share by Region (2021-2026)
Figure 19. Americas Microfluidic in Vitro Diagnostics Market Size 2021-2026 ($ millions)
Figure 20. APAC Microfluidic in Vitro Diagnostics Market Size 2021-2026 ($ millions)
Figure 21. Europe Microfluidic in Vitro Diagnostics Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Microfluidic in Vitro Diagnostics Market Size 2021-2026 ($ millions)
Figure 23. Americas Microfluidic in Vitro Diagnostics Value Market Share by Country in 2025
Figure 24. United States Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Microfluidic in Vitro Diagnostics Market Size Market Share by Region in 2025
Figure 29. APAC Microfluidic in Vitro Diagnostics Market Size Market Share by Type (2021-2026)
Figure 30. APAC Microfluidic in Vitro Diagnostics Market Size Market Share by Application (2021-2026)
Figure 31. China Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 35. India Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Microfluidic in Vitro Diagnostics Market Size Market Share by Country in 2025
Figure 38. Europe Microfluidic in Vitro Diagnostics Market Size Market Share by Type (2021-2026)
Figure 39. Europe Microfluidic in Vitro Diagnostics Market Size Market Share by Application (2021-2026)
Figure 40. Germany Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 41. France Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Microfluidic in Vitro Diagnostics Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Microfluidic in Vitro Diagnostics Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Microfluidic in Vitro Diagnostics Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 54. APAC Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 55. Europe Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 57. United States Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 58. Canada Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 59. Mexico Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 60. Brazil Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 61. China Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 62. Japan Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 63. Korea Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 65. India Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 66. Australia Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 67. Germany Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 68. France Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 69. UK Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 70. Italy Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 71. Russia Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 72. Egypt Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 73. South Africa Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 74. Israel Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 75. Turkey Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 76. Global Microfluidic in Vitro Diagnostics Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Microfluidic in Vitro Diagnostics Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 1. Microfluidic in Vitro Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Microfluidic in Vitro Diagnostics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Microfluidic in Vitro Diagnostics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Microfluidic in Vitro Diagnostics Sales Market Share by Country/Region (2025)
Figure 8. Microfluidic in Vitro Diagnostics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Microfluidic in Vitro Diagnostics Market Size Market Share by Type in 2025
Figure 10. Microfluidic in Vitro Diagnostics in Hospital
Figure 11. Global Microfluidic in Vitro Diagnostics Market: Hospital (2021-2026) & ($ millions)
Figure 12. Microfluidic in Vitro Diagnostics in Third-party Laboratory
Figure 13. Global Microfluidic in Vitro Diagnostics Market: Third-party Laboratory (2021-2026) & ($ millions)
Figure 14. Microfluidic in Vitro Diagnostics in Other
Figure 15. Global Microfluidic in Vitro Diagnostics Market: Other (2021-2026) & ($ millions)
Figure 16. Global Microfluidic in Vitro Diagnostics Market Size Market Share by Application in 2025
Figure 17. Global Microfluidic in Vitro Diagnostics Revenue Market Share by Player in 2025
Figure 18. Global Microfluidic in Vitro Diagnostics Market Size Market Share by Region (2021-2026)
Figure 19. Americas Microfluidic in Vitro Diagnostics Market Size 2021-2026 ($ millions)
Figure 20. APAC Microfluidic in Vitro Diagnostics Market Size 2021-2026 ($ millions)
Figure 21. Europe Microfluidic in Vitro Diagnostics Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Microfluidic in Vitro Diagnostics Market Size 2021-2026 ($ millions)
Figure 23. Americas Microfluidic in Vitro Diagnostics Value Market Share by Country in 2025
Figure 24. United States Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Microfluidic in Vitro Diagnostics Market Size Market Share by Region in 2025
Figure 29. APAC Microfluidic in Vitro Diagnostics Market Size Market Share by Type (2021-2026)
Figure 30. APAC Microfluidic in Vitro Diagnostics Market Size Market Share by Application (2021-2026)
Figure 31. China Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 35. India Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Microfluidic in Vitro Diagnostics Market Size Market Share by Country in 2025
Figure 38. Europe Microfluidic in Vitro Diagnostics Market Size Market Share by Type (2021-2026)
Figure 39. Europe Microfluidic in Vitro Diagnostics Market Size Market Share by Application (2021-2026)
Figure 40. Germany Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 41. France Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Microfluidic in Vitro Diagnostics Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Microfluidic in Vitro Diagnostics Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Microfluidic in Vitro Diagnostics Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Microfluidic in Vitro Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 54. APAC Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 55. Europe Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 57. United States Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 58. Canada Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 59. Mexico Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 60. Brazil Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 61. China Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 62. Japan Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 63. Korea Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 65. India Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 66. Australia Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 67. Germany Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 68. France Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 69. UK Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 70. Italy Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 71. Russia Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 72. Egypt Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 73. South Africa Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 74. Israel Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 75. Turkey Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
Figure 76. Global Microfluidic in Vitro Diagnostics Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Microfluidic in Vitro Diagnostics Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Microfluidic in Vitro Diagnostics Market Size 2027-2032 ($ millions)
